XBRANE — Xbrane Biopharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Xbrane Biopharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	—	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	295	194	65.4	124	86.6
Net Total Accounts Receivable
Net Total Receivables	50.3	47.5	34.2	33.8	12.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	561	514	462	606	375
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	73.8	71	88.2	64.9	0.036
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	688	691	654	842	672
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	220	237	327	538	52.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	257	266	482	634	111
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	432	425	171	209	561
Total Liabilities & Shareholders' Equity	688	691	654	842	672
Total Common Shares Outstanding